The pharmaceutical giant named Jeffrey Legos the head of a division it is counting on to overcome investor pressure and grow ...

The deal was signed with the Energize programme, a renewable energy purchasing vehicle for pharmeceutical companies.

January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.